Drug development
Measuring bronchodilation in COPD clinical trials
Quantifying Bronchodilator Responses in Chronic Obstructive Pulmonary Disease Trials
Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography
Absence of circadian variation in the pharmacokinetics of lopinavir/ritonavir given as a once daily dosing regimen in HIV-1-infected patients
Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer
Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects
Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein
Self treatment with one of three self selected, ultramolecular homeopathic medicines for the prevention of upper respiratory tract infections in children. A double-blind randomized placebo controlled trial
Ineffectiveness of lipid-lowering therapy in primary care
The teaching of drug development to medical students
Therapeutic innovation in the European Union
Raloxifene pharmacokinetics in males with normal and impaired renal function
Insertion/deletion polymorphism of the ACE gene and adherence to ACE inhibitors
Co-administration of oxycodone and morphine and analgesic synergy re-examined
Coadministration of oxycodone and morphine and analgesic synergy re-examined
Different accumulation of temocapril and enalapril during repeated dosing in elderly patients